All services

What you actually pay in tax when you sell your pharmacy.

On a qualifying pharmacy disposal, Business Asset Disposal Relief charges CGT at 18% for 2026/27 on gains up to the £1m lifetime limit per person. Beyond that, standard CGT applies at 18% within the basic-rate band and 24% above it, against a £3,000 annual exempt amount. The BADR rate has stepped up from 10% before 2025/26, to 14% in 2025/26, to 18% from 6 April 2026, which means the timing of your exit is a real money decision. Deal structure, earn-outs, and deferred consideration change when the tax falls due. We plan the exit before heads of terms are agreed, not after.

18%
BADR rate for 2026/27 on qualifying pharmacy disposals up to the £1m lifetime limit per person (up from 14% in 2025/26)
18% / 24%
Standard CGT beyond BADR: 18% within the remaining basic-rate band, 24% above it, with a £3,000 annual exempt amount
£1m per person
BADR lifetime limit: each qualifying individual has their own £1m limit, not shared across a couple or business

The challenges clients face.

BADR eligibility and the qualifying conditions

BADR is not automatic on a pharmacy sale. The qualifying conditions, including the two-year holding period, must be met. Getting the eligibility check wrong before exchange leaves money on the table or creates a nasty post-completion surprise. We verify the conditions before you agree heads of terms, when there is still time to act.

Standard CGT beyond BADR is not a flat rate

Above the £1m BADR limit, or where BADR does not apply, CGT is 18% on gains within the remaining basic-rate band and 24% on gains above it. Many sellers and their advisers quote a flat rate, which is wrong and either overstates or understates the liability. The £3,000 annual exempt amount applies for 2026/27 before any CGT is due.

Earn-outs and deferred consideration change when the tax falls due

Where some of the sale price is deferred or contingent, the CGT timing rules mean some of the gain may fall into a later tax year, potentially at a different rate. This is real planning territory, particularly given the step-up in BADR rates in recent years. Structuring an earn-out without modelling the tax timing is a costly oversight.

Goodwill dominates the gain

On most pharmacy sales, goodwill is the largest component of the gain because it reflects the NHS contract and prescription volume. The gain on goodwill must be computed correctly, and where the pharmacy is held in a company, the share sale route changes how the gain is taxed compared with an asset sale.

How we help.

BADR eligibility review and pre-sale planning

We review the qualifying conditions before exchange and advise on any steps that might be needed. Where the BADR rate history matters to your timing decision, we model the outcomes. The rate was 10% before 2025/26, 14% in 2025/26, and is 18% from 6 April 2026, per HMRC guidance. We do not assume eligibility; we verify it.

Deal structure and earn-out modelling

We model the CGT outcome under different deal structures, including upfront consideration, earn-outs, and deferred payments. Where the timing of the gain falling due changes the tax position, we show the options before you commit to heads of terms. We coordinate with your solicitor and broker on the structure.

CGT computation and Self Assessment filing

We compute the gain, apply BADR and the annual exempt amount correctly, prepare the Self Assessment return, and handle any HMRC correspondence. Where an advance CGT payment is required, we calculate and manage it. For significant disposals involving complex earn-outs, we also prepare the provisional figures your broker may need during due diligence.

Common questions

How much CGT will I pay when I sell my pharmacy?
On a qualifying disposal, BADR applies at 18% for 2026/27 on gains up to your £1m lifetime limit. Beyond that, standard CGT is 18% within the remaining basic-rate band and 24% above it. The £3,000 annual exempt amount reduces the gain before any CGT is due. The exact figure depends on the gain, your other income, and whether BADR conditions are met. Speak to us before you agree terms so we can model it.
Did the BADR rate change, and does it affect timing my sale?
Yes. BADR was 10% before 2025/26, rose to 14% in 2025/26, and rose again to 18% from 6 April 2026. The rate is now materially higher than it was, which changes the value of BADR relative to a deferred exit. Timing a disposal around rate changes is a genuine planning decision, not a theoretical one. We model the outcomes for your specific exit.
Is the £1m BADR limit per person or per sale?
Per person, and it is a lifetime limit. Each qualifying individual has their own £1m limit across all BADR-qualifying disposals in their lifetime, not just this one sale. Where a couple each have a qualifying interest, each has their own £1m. We track remaining headroom as part of the eligibility check.
How does an earn-out affect my CGT position?
An earn-out or deferred payment changes when the tax falls due. Where consideration is contingent or deferred, HMRC's rules on the timing of the disposal and the valuation of uncertain consideration apply. This is planning territory with real money at stake. Route this to us before the deal structure is finalised.

Speak to a pharmacy finance specialist.

Tell us about your situation and we will reply within 24 hours.

Step 1 of 2 · About you

Optional: a bit more detail (helps us prepare)